Article Information
PubMed
Print ISSN
Online ISSN
History
- Received February 21, 2022
- Accepted May 12, 2022
- Published online July 25, 2022.
Article Versions
- Earlier version (May 30, 2022 - 12:44).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2022 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Yueping Zhang,
- Shen-Jue Chen,
- Cliff Chen,
- Xue-Qing Chen,
- Sagnik Chatterjee,
- David J. Shuster,
- Heather Dexter,
- Laura Armstrong,
- Elizabeth M. Joshi,
- Zheng Yang, and
- Hong Shen
- Drug Metabolism and Pharmacokinetics (Y.Z., C.C, E.M.J., Z.Y., H.S.), Discovery Toxicology (S.-J.C., L.A.), Discovery Pharmaceutics (X.-Q.C.), and Veterinary Sciences (D.J.S., H.D.), Bristol Myers Squibb Company, Princeton, New Jersey; and Drug Metabolism and Pharmacokinetics (S.-J.C.), Biocon Bristol Myers Squibb R&D Centre, Syngene International Ltd., Bangalore, India
- Address correspondence to:
Dr. Hong Shen, Scientific Director, Drug Metabolism and Pharmacokinetics (DMPK) Department, Pharmaceutical Candidate Optimization (PCO), Bristol Myers Squibb Company (BMS), Route 206 & Province Line Road, Princeton, NJ 08543. E-mail: hong.shen1{at}bms.com